117 related articles for article (PubMed ID: 11137845)
1. Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
Goldsmith IR; Blann AD; Patel RL; Lip GY
Am J Cardiol; 2001 Jan; 87(1):107-10, A9. PubMed ID: 11137845
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
Goldsmith IR; Blann AD; Patel RL; Lip GY
Am J Cardiol; 2000 May; 85(10):1218-22. PubMed ID: 10802004
[TBL] [Abstract][Full Text] [Related]
3. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
Lip GY; Edmunds E; Hee FL; Blann AD; Beevers DG
Am J Hypertens; 2001 Aug; 14(8 Pt 1):823-8. PubMed ID: 11497201
[TBL] [Abstract][Full Text] [Related]
5. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
6. Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction.
Goldsmith IR; Blann AD; Patel RL; Lip GY
Heart; 2000 May; 83(5):577-8. PubMed ID: 10768913
[No Abstract] [Full Text] [Related]
7. Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
Goldsmith IR; Foo LS; Blann AD; Lip GY
Clin Cardiol; 2000 Aug; 23(8):587-90. PubMed ID: 10941544
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
9. Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study.
Chan V; Jamieson WR; Lam BK; Ruel M; Ling H; Fradet G; Mesana TG
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1053-8.e2. PubMed ID: 20546795
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesis.
Emery RW; Krogh CC; McAdams S; Emery AM; Holter AR
J Heart Valve Dis; 2010 Jul; 19(4):473-84. PubMed ID: 20845896
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Lip GY; Lydakis C; Nuttall SL; Landray MJ; Watson RD; Blann AD
J Intern Med; 2000 Oct; 248(4):316-8. PubMed ID: 11086642
[TBL] [Abstract][Full Text] [Related]
12. Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Blann AD; Gurney D; Wadley M; Bareford D; Stonelake P; Lip GY
Blood Coagul Fibrinolysis; 2001 Jan; 12(1):43-50. PubMed ID: 11229826
[TBL] [Abstract][Full Text] [Related]
13. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Gibbs CR; Blann AD; Watson RD; Lip GY
Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
[TBL] [Abstract][Full Text] [Related]
15. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee KW; Blann AD; Lip GY
Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
[TBL] [Abstract][Full Text] [Related]
16. A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation.
Fu R; Wu S; Wu P; Qiu J
Europace; 2011 Jan; 13(1):31-6. PubMed ID: 20852292
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.
Landray MJ; Wheeler DC; Lip GY; Newman DJ; Blann AD; McGlynn FJ; Ball S; Townend JN; Baigent C
Am J Kidney Dis; 2004 Feb; 43(2):244-53. PubMed ID: 14750089
[TBL] [Abstract][Full Text] [Related]
18. Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement.
Yamashita K; Yagi H; Hayakawa M; Abe T; Hayata Y; Yamaguchi N; Sugimoto M; Fujimura Y; Matsumoto M; Taniguchi S
J Atheroscler Thromb; 2016 Oct; 23(10):1150-1158. PubMed ID: 27052664
[TBL] [Abstract][Full Text] [Related]
19. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
20. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
Circulation; 2002 Oct; 106(15):1962-7. PubMed ID: 12370220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
